Geben Sie eine Aktie oder eine Kryptowährung in der Suchleiste an, um eine Zusammenfassung zu erhalten
Uniphar Group PLC
OvervaluedAbschluss
🧐 Extreme Unsicherheit, sehr hohes Risiko, untersuchen Sie alle Aspekte mit großer Sorgfalt, es gibt offensichtlich transparentere Unternehmen als Alternative.
Similar to Uniphar Group PLC

OMI
Owens & Minor IncTLIK
TELES Informationstechnologien AGARJO-B
Arjo AB (publ)CYC
Cyclopharm LtdEDAP
EDAP TMS SAUniphar Group PLC
UPRUniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, The Netherlands, and internationally. The company operates through three divisions: Medtech, Pharma, and Supply Chain & Retail. The Medtech division offers outsourced sales; and marketing, distribution, and support services to medical device manufacturers. The Pharma division provides high value services across the lifecycle of a pharmaceutical product; and healthcare professionals with access to medicines it cannot source through traditional channels, as well as operates its on demand and pharma service units. The Supply Chain & Retail division engages in pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and veterinary surgeons; and operates a network of pharmacies under the Life, Allcare, and Hickey's brands. It also offers pharmacy support, pharmaceutical supply chain, specialist nursing and infusion, medical device distribution, healthcare technology, outsourcing and resourcing, telecommunications support, pharmaceutical advisory, medical affairs, and online pharmacy and product fostering services, as well as specialist provider of pharmaceuticals. Uniphar plc was founded in 1967 and is headquartered in Dublin, Ireland. Address: 4045 Kingswood Road, Dublin, Ireland, D24 V06K
Analytics
Zielpreis von Wall Street
4.26 EURKGV
11.54Dividendenrendite
–Schlüsselzahlen UPR
- Gewinnspanne
- Gesamtumsatz
- Bruttogewinn
- Nettogewinn
Dividenden-Analyse UPR
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y>5 - expected 5-9 dividend yield on cost over 10Y<5 - expected <5 dividend yield on cost over 10YMaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–Dividendenwachstum über 5 Jahre
–Kontinuierliches Wachstum
–Ausschüttungsquote 5-Jahres-Durchschnitt
8.00 %Verlauf der Dividende UPR
- Auszahlungsquote
- Dividends
- Dividendenrendite
Bewertung der Aktie UPR
- KUV
- KGV
- Kurs-Buchwert-Verhältnis
- Liquiditätsgrad
- Verschuldungsgrad
Finanzen UPR
Ergebnisse | 31.12.2016 | 31.12.2017 | 31.12.2018 | 31.12.2019 | 31.12.2020 | 31.12.2021 | 31.12.2022 | 31.12.2023 | Dynamik | |
Gesamtumsatz | 1 304 260 911 EUR | 1 275 181 865 EUR | 1 561 607 752 EUR | 1 675 484 081 EUR | 1 835 026 444 EUR | 1 955 052 214 EUR | 2 083 353 367 EUR | 2 568 701 378 EUR | ||
Betriebseinnahmen | 17 221 854 EUR | 10 986 893 EUR | 36 924 814 EUR | 40 435 187 EUR | 47 005 187 EUR | 59 915 793 EUR | 53 480 613 EUR | 78 219 232 EUR | ||
Nettogewinn - (CF) | 5 773 149 EUR | -1 034 297 EUR | 17 405 975 EUR | 21 154 799 EUR | 27 997 461 EUR | 48 371 506 EUR | 45 866 253 EUR | 45 089 524 EUR | ||
Normalisiertes Basis-EPS | 0.02 EUR | - | 0.07 EUR | 0.12 EUR | 0.12 EUR | 0.20 EUR | 0.18 EUR | 0.18 EUR | ||
Dividende pro Aktie | 0.00 EUR | 0.00 EUR | 0.00 EUR | 0.00 EUR | 0.01 EUR | 0.02 EUR | 0.02 EUR | 0.01 EUR | ||
Auszahlungsquote | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 6.57 % | 10.93 % | 9.77 % | 6.57 % | ||
Gesamtvermögen | 289 377 859 EUR | 291 305 596 EUR | 658 911 743 EUR | 765 282 374 EUR | 845 603 403 EUR | 950 781 775 EUR | 1 117 598 428 EUR | 1 297 460 507 EUR | ||
Gesamtverbindlichkeiten | 299 638 329 EUR | 302 093 275 EUR | 509 099 621 EUR | 583 254 106 EUR | 641 827 728 EUR | 697 676 761 EUR | 826 040 294 EUR | 961 796 840 EUR | ||
Verschuldungsgrad | 1.04 | 1.04 | 0.77 | 0.76 | 0.76 | 0.73 | 0.74 | 0.74 | ||
Gesamtumlaufvermögen | 193 438 739 EUR | 185 444 064 EUR | 372 065 296 EUR | 361 251 457 EUR | 308 446 959 EUR | 346 101 215 EUR | 429 788 742 EUR | 511 045 468 EUR | ||
Gesamtverbindlichkeiten | 262 340 242 EUR | 270 300 709 EUR | 347 314 603 EUR | 350 298 771 EUR | 350 897 417 EUR | 375 996 229 EUR | 436 257 124 EUR | 577 479 950 EUR | ||
Liquiditätsgrad | 0.74 | 0.69 | 1.07 | 1.03 | 0.88 | 0.92 | 0.99 | 0.89 | ||
Schnellliquiditätsgrad | 0.56 | 0.49 | 0.84 | 0.75 | 0.55 | 0.62 | 0.62 | 0.56 | ||
ROA | 2.00 % | -0.36 % | 2.64 % | 2.76 % | 3.31 % | 5.09 % | 4.10 % | 3.48 % | ||
FFO-Zinsdeckung | 3.35 | -0.01 | 4.33 | 5.08 | 6.72 | 9.05 | 5.72 | 5.72 * | ||
KGV - P/E (LTM) | - | - | - | 10.99 | 25.21 | 28.54 | 18.20 | 16.74 | ||
Dividendenrendite (LTM) | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.26 % | 0.38 % | 0.54 % | 0.39 % | ||
Rückkaufrendite (LTM) | - | - | - | 31.82 % | -42.98 % | - | -4.03 % | -4.03 % * |